logo







Home>Companies>Guardant-health


Guardant health

Guardant health



Guardant Health is a biotechnology company specializing in liquid-based cancer diagnostics and research services.
Sign up today to get real-time market insights on Guardant health and hundreds of other pre-IPO companies



Guardant health Overview

Palo Alto, CA, United States
2011
Biotech
https://www.guardanthealth.com



Guardant health Live Market Data

$00000000
$00000000




Guardant health Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO10/4/2018
Series E5/11/2017
Series D3/24/2016
Series C3/27/2015
Series B7/9/2014
Series A
2/14/2014




Guardant health Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Cota CapitalSeries ASeries A (2014-02-14)
Plug and Play Tech CenterSeries ASeries A (2014-02-14)
Sequoia CapitalSeries E, Series A, Series C, Series D, Series BSeries E (2017-05-11)
Highbury GroupSeries B, Series CSeries B (2014-07-09)
Khosla VenturesSeries B, Series E, Series C, Series DSeries B (2014-07-09)
Pear (California)Series B, Series C, Series DSeries B (2014-07-09)
Signatures Capital
Series B
Series B (2014-07-09)




Guardant health 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Guardant health data




Guardant health Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Guardant health data




Latest Guardant health News







Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.